UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Isolated limb perfusion with high-dose tumor necrosis factor-alpha in combination with interferon-gamma and melphalan for nonresectable extremity soft tissue sarcomas: a multicenter trial

Journal of clinical oncology, 1996-10, Vol.14 (10), p.2653-2665

1996

Volltextzugriff (PDF)

Sunscreen Use and Duration of Sun Exposure: a Double-Blind, Randomized Trial

JNCI : Journal of the National Cancer Institute, 1999-08, Vol.91 (15), p.1304-1309

1999

Volltextzugriff (PDF)

High-dose recombinant tumor necrosis factor alpha in combination with interferon gamma and melphalan in isolation perfusion of the limbs for melanoma and sarcoma

Journal of clinical oncology, 1992-01, Vol.10 (1), p.52-60

1992

Volltextzugriff (PDF)

p53 status correlates with histopathological response in patients with soft tissue sarcomas treated using isolated limb perfusion with TNF-α and melphalan

Annals of oncology, 2008-04, Vol.19 (4), p.793-800

2008

Volltextzugriff (PDF)

Limb salvage by neoadjuvant isolated perfusion with TNFα and melphalan for non-resectable soft tissue sarcoma of the extremities

European journal of surgical oncology, 2000-11, Vol.26 (7), p.669-678

2000

Volltextzugriff (PDF)

Isolated liver perfusion for non-resectable liver tumours: a review

European journal of surgical oncology, 2002-12, Vol.28 (8), p.875-890

2002

Volltextzugriff (PDF)

Isolated limb perfusion with tumour necrosis factor-alpha and melphalan with or without interferon-gamma for the treatment of in-transit melanoma metastases: a multicentre randomized phase II study

Melanoma research, 1999-10, Vol.9 (5), p.491-502

1999

Volltextzugriff (PDF)

Evidence for the involvement of endothelial cell integrin alpha V beta 3 in the disruption of the tumor vasculature induced by TNF and IFN- gamma

Nature medicine, 1998-04, Vol.4 (4), p.408-414

1998

Volltextzugriff (PDF)

Le traitement des métastases en transit de mélanome par la perfusion de membre isolé

Oncologie (Paris, France), 2000, Vol.2 (1), p.85-89

LEJEUNE, F. J

2000

Volltextzugriff (PDF)

High tPA-expression in primary melanoma of the limb correlates with good prognosis

British journal of cancer, 2000-11, Vol.83 (10), p.1351-1359

2000

Volltextzugriff (PDF)

Lack of BRAF mutations in uveal melanoma

Cancer research (Chicago, Ill.), 2003-09, Vol.63 (18), p.5712-5715

2003

Volltextzugriff (PDF)

High dose recombinant tumour necrosis factor (rTNFα) administered by isolation perfusion for advanced tumours of the limbs: a model for biochemotherapy of cancer

European journal of cancer (1990), 1995-06, Vol.31 (6), p.1009-1016

Lejeune, F.J.

1995

Volltextzugriff (PDF)

Clinical applications of TNF-α in cancer

Current opinion in immunology, 1998-10, Vol.10 (5), p.573-580

1998

Volltextzugriff (PDF)

Prognostic value of sentinel node biopsy in 327 prospective melanoma patients from a single institution

European journal of surgical oncology, 2008-06, Vol.34 (6), p.673-679

2008

Volltextzugriff (PDF)

Prophylactic isolated limb perfusion for localized, high-risk limb melanoma : Results of a multicenter randomized phase III trial

Journal of clinical oncology, 1998-09, Vol.16 (9), p.2906-2912

1998

Volltextzugriff (PDF)

In transit metastases of malignant melanoma treated by high dose rTNFα in combination with interferon‐γ and melphalan in isolation perfusion

World journal of surgery, 1992-03, Vol.16 (2), p.234-240

1992

Volltextzugriff (PDF)

Isolation limb perfusion with tumor necrosis factor alpha and chemotherapy for advanced extremity soft tissue sarcomas: Sarcomas

Seminars in oncology, 1997-10, Vol.24 (5), p.547-555

1997

Volltextzugriff (PDF)

Isolated limb perfusion with tumor necrosis factor and melphalan for limb salvage in 186 patients with locally advanced soft tissue extremity sarcomas. The cumulative multicenter European experience

Annals of surgery, 1996-12, Vol.224 (6), p.756-765

1996

Volltextzugriff (PDF)

Sentinel lymph node involvement and a high Breslow index are independent factors of risk for early relapse of melanoma

Nuclear medicine, 2007-01, Vol.46 (6), p.244

2007

Volltextzugriff (PDF)

VWF release and platelet aggregation in human melanoma after perfusion with TNFα

The Journal of pathology, 1995-07, Vol.176 (3), p.279-287

1995

Volltextzugriff (PDF)

Evidence for alpha‐melanocyte‐stimulating hormone (α‐MSH) receptors on human malignant melanoma cells

International journal of cancer, 1988-02, Vol.41 (2), p.248-255

1988

Volltextzugriff (PDF)

Regional therapy of melanoma

European journal of cancer (1990), 1993, Vol.29 (4), p.606-612

1993

Volltextzugriff (PDF)

What is the impact of sentinel node biopsy in the management of cancer?

Annals of oncology, 2005-08, Vol.16 (8), p.1217-1218

Lejeune, F.J.

2005

Volltextzugriff (PDF)

Phase I-II study on isolation antiblastic fotemustine perfusion after dacarbazine chemosensitization for advanced melanoma of the extremities

Melanoma research, 2003-06, Vol.13 (3), p.293-297

2003

Volltextzugriff (PDF)

Complete remission of advanced cutaneous leiomyosarcoma following isolated limb perfusion with high-dose tumour necrosis factor-α and melphalan

British journal of dermatology (1951), 1999-11, Vol.141 (5), p.935-936

1999

Volltextzugriff (PDF)

1 – 25 von 1.193

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(928)
Mit Volltextzugriff
(799)

Publikationsform

3 weitere anzeigen...

Weniger anzeigen...

Sprache

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

Menü

Weitere Dienste

Einstellungen

Isolated limb perfusion with high-dose tumor necrosis factor-alpha in combination with interferon-gamma and melphalan for nonresectable extremity soft tissue sarcomas: a multicenter trial

Sunscreen Use and Duration of Sun Exposure: a Double-Blind, Randomized Trial

High-dose recombinant tumor necrosis factor alpha in combination with interferon gamma and melphalan in isolation perfusion of the limbs for melanoma and sarcoma

p53 status correlates with histopathological response in patients with soft tissue sarcomas treated using isolated limb perfusion with TNF-α and melphalan

Limb salvage by neoadjuvant isolated perfusion with TNFα and melphalan for non-resectable soft tissue sarcoma of the extremities

Isolated liver perfusion for non-resectable liver tumours: a review

Isolated limb perfusion with tumour necrosis factor-alpha and melphalan with or without interferon-gamma for the treatment of in-transit melanoma metastases: a multicentre randomized phase II study

Evidence for the involvement of endothelial cell integrin alpha V beta 3 in the disruption of the tumor vasculature induced by TNF and IFN- gamma

Le traitement des métastases en transit de mélanome par la perfusion de membre isolé

High tPA-expression in primary melanoma of the limb correlates with good prognosis

Lack of BRAF mutations in uveal melanoma

High dose recombinant tumour necrosis factor (rTNFα) administered by isolation perfusion for advanced tumours of the limbs: a model for biochemotherapy of cancer

Clinical applications of TNF-α in cancer

Prognostic value of sentinel node biopsy in 327 prospective melanoma patients from a single institution

Prophylactic isolated limb perfusion for localized, high-risk limb melanoma : Results of a multicenter randomized phase III trial

In transit metastases of malignant melanoma treated by high dose rTNFα in combination with interferon‐γ and melphalan in isolation perfusion

Isolation limb perfusion with tumor necrosis factor alpha and chemotherapy for advanced extremity soft tissue sarcomas: Sarcomas

Isolated limb perfusion with tumor necrosis factor and melphalan for limb salvage in 186 patients with locally advanced soft tissue extremity sarcomas. The cumulative multicenter European experience

Sentinel lymph node involvement and a high Breslow index are independent factors of risk for early relapse of melanoma

VWF release and platelet aggregation in human melanoma after perfusion with TNFα

Evidence for alpha‐melanocyte‐stimulating hormone (α‐MSH) receptors on human malignant melanoma cells

Regional therapy of melanoma

What is the impact of sentinel node biopsy in the management of cancer?

Phase I-II study on isolation antiblastic fotemustine perfusion after dacarbazine chemosensitization for advanced melanoma of the extremities

Complete remission of advanced cutaneous leiomyosarcoma following isolated limb perfusion with high-dose tumour necrosis factor-α and melphalan

Suchergebnisse filtern